PHI1.DEPHI1.DEXETRA
Loading
EBITDA Over TimeExpanding
Percentile Rank93
5Y CAGR+1.2%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

5Y CAGR
+1.2%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$2.71B+46.3%
2024$1.85B+77.6%
2023$1.04B+471.8%
2022$-280.00M-116.2%
2021$1.73B-32.2%
2020$2.56B-5.0%
2019$2.69B+1.9%
2018$2.64B+1.3%
2017$2.61B+5.4%
2016$2.47B-